Ocular Surface Microbiome in Dry Eye Patients
Exploratory Study on the Ocular Surface Microbiome and Correlation to Clinical Parameters
2 other identifiers
observational
82
1 country
1
Brief Summary
The ocular surface is the first line of defence of the eye, it is therefore where external threats are sensed, and potential insults neutralised. Over the course of evolution, various microbes, especially bacteriae, have come to colonise the ocular surface as commensals. The commensals have a role to maintain the homeostasis of the ocular surface. 1 The innate immunity of the ocular surface is very active, and consists of active mechanisms to suppress inflammation 2. For example, there exist macrophages, dendritic cells, suppressor cells, regulatory cells, B cells, IgA, lysozyme, anti-microbial peptides and barriers against external agents. The normal commensals of the ocular surface maintain a basal level of activation of innate defence by stimulating the pattern recognition receptors on ocular surface epithelial cells. This normal composition of microbes is important since inflammation and infection will result if there is introduction of a pathogenic strain that overcomes the flora, or if a dominant strain secretes excessively immunogenic products, such as the exotoxin A of Staphylococcus which triggers marginal keratitis, a form of type IV hypersensitivity. The flora load of microbiome could also influence tear function as a higher flora load was found to be associated with increased mucin degradation 3 and reduced globet cell densitiy 4. Previous studies \[I'm not sure which studies these are\] at SERI/SNEC also point to the importance of microbes. For example, in dry eye patients, there is increased lysophospholipids in the tear, and this may contribute to inflammatory mediators such as arachidonic acid and other metabolites. The lysophospholipids are formed by phospholipase A2 reactions, and the latter may be microbial in origin. Since dry eye is a known inflammatory disease of the ocular surface, this is one way that microbes can contribute to the pathology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 9, 2014
CompletedFirst Posted
Study publicly available on registry
June 11, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedOctober 31, 2018
October 1, 2018
4.3 years
June 9, 2014
October 29, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
bacterial microbiome
Determine the composition of the bacterial microbiome of the human ocular surface in normal volunteers and dry eye patients
1 day
Secondary Outcomes (2)
Gene expression
1 day
Clinical characteristic
1 day
Eligibility Criteria
Dry eye patients and healthy normal volunteers
You may qualify if:
- Subjects must be 21 years or older
- Willing to perform all the eye examinations in this study
You may not qualify if:
- Known history of thyroid disorders (diagnosed by physician).
- Known history of Sjogren syndrome or rheumatoid arthritis (diagnosed by physician).
- No ocular surgery within the last 3 months and LASIK within 1 year.
- Ocular surface diseases such as pterygium, or obvious lid/orbital disease with lagophthalmos.
- Any other specified reason as determined by clinical investigator.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Singapore Eye Research Institute
Singapore, 168751, Singapore
Biospecimen
Microbiome swab will be collected from the inferior fornix of the lower eyelids to determine composition of the bacterial microbiome of the human ocular surface in normal volunteers and dry eye patients
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinician-Scientist, Senior Consultant
Study Record Dates
First Submitted
June 9, 2014
First Posted
June 11, 2014
Study Start
June 1, 2014
Primary Completion
October 1, 2018
Study Completion
October 1, 2018
Last Updated
October 31, 2018
Record last verified: 2018-10